small business profiles canada

Aarkstore announce a new report "The Future of the Biodefense Industry: Regulation, funding opportunities and profiles business "through its vast collection of market research report.

The largest contemporary bioterrorism event has opened research programs and development (R & D) in pharmaceutical countermeasures and treatments was the Anthrax attacks of email came only weeks after 9 / 11 atrocities, in October 2001. Shipments killed five people and exposed hundreds more – with thousands of U.S. citizens antibiotics for prophylactic. Since then, the biological defense industry has grown tremendously, with the U.S. the release of about $ 50 billion in funding for biodefense in 2001-2009. Other international agencies such as the EU also increased its surveillance and research efforts.

This report is intended describe and analyze the work of the biodefense industry in terms of pharmaceutical research past, present and future, development and production for counteract or treat diseases caused by biological attack. It also describes government policies and initiatives in several countries that have stimulated research and production in pharmaceutical countermeasures and treatments for these diseases and review the various factors influencing the policies and the market, including current and future threats and how the industry is responding to new discoveries.

Scope of this report

• Analysis of levels of government funding in the U.S. and Europe and information on current grants available for research biodefense.

• Estimation of biodefense in the U.S. 2010 and projected to 2012 figures.

• In-depth analysis of the major companies operating in the U.S. biodefense, Europe, Australia and Canada, as well as those operating in emerging markets like China, India and Israel.

• Analysis of the areas of greatest threat in the biodefense market including – Anthrax, plague, tularemia, smallpox, viral hemorrhagic fevers small botulism, ricin, staphylococcal enterotoxin, brucellosis, glanders, melioidosis and Q fever

Key findings This report

• The U.S. is driving the biodefense industry and total funding between 2001-2009 reached $ 49.6bn. However, growth is to slow significantly in coming years as the Project BioShield funding all been released.

• However, a single serious incident of bioterrorism in the U.S. could trigger a new round of government spending, as occurred after the Anthrax attacks of 2001. Recent threats such as pandemic flu swine are also forcing governments to consider the creation of large stockpiles of medical countermeasures.

• The current economic crisis could be particularly serious for the biodefense industry. Like many of the active participants are small scale and depend on funding abroad to maintain its operations, reduced credit options might force them to leave the company

Key issues

• Since 2001 funding for U.S. Biodefense have reached $ 49.6bn. The peak year for spending was 2005, due to the wide dissemination of funds under the Project BioShield, however, 2009 also saw a big investment.

• In 2010, Business Insights estimates that the funding total in the U.S. biodefense reach $ 5,932 mn. If you were to take BioShield funding figures for 2009, after 2010 represents an increase of 1.4% (year a year), a reversal of the trend between 2006-2008.

• There have been only a small number of terrorist incidents the last thirty years, with the remaining deaths limited. However, partly due to psychological fear created by these weapons, the U.S. military in particular, has invested heavily in the preparation of vaccines and therapeutics.

• The rarity of bioterrorist attacks, due to the extreme difficulty in militarization and delivery of biological agents, has caused many groups of scientists to criticize the current levels of high spending on research on measures to combat doctor.

Use this report to:

• What are the trends main drivers of bio-defense market?

• What is the current state of R & D in the biodefense market?

• How has the regulatory pathway in recent years and how this development of the industry to make?

• What are the current levels of funding for biological defense and what is the prognosis for 2010-2012?

• What areas of products provide the greatest opportunity for future development?

  For more information, visit:
  target = "_blank" href = "http://www.aarkstore.com/reports/The-Future-of-the-Biodefense-Industry-Regulation-funding-opportunities-company-profiles-34851.html" http:// www.aarkstore.com/reports/The-Future-of-the-Biodefense-Industry-Regulation-funding-opportunities-company-profiles-34851.html
  Or e-mail to press@aarkstore.com or call +919272852585

  Special offer until December 31, 2009

About the Author:

Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers. Our customers include more than 700 leading financial institutions, professional service firms, consulting, law and accounting firms and other corporations throughout the world.

Article Source: ArticlesBase.com – The Future of the Biodefense Industry: Regulation, funding opportunities & company profiles–Aarkstore Enterprise

2. Small Business Marketplace for Selling Services and Products – http://www.bizdrive.biz

Small presbytery big on ideas: Paris sees ‘growth in true participation’.(presbytery profile)(Paris, Ontario): An article from: Presbyterian Record $9.95 This digital document is an article from Presbyterian Record, published by Thomson Gale on September 1, 2006. The length of the article is 1188 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Small…

Small business in Canada: A statistical profile, 1982-1984 (Catalogue) …

Small business in Canada: A statistical profile 1981-1983 …